Skip to content

Do Ovaries Do Anything After 65? A Look at Postmenopausal Function

4 min read

While menopause marks the end of reproductive years and a significant drop in estrogen, the ovaries do not simply become inert. The question, do ovaries do anything after 65, reveals a common misconception, as these organs continue to produce important hormones that influence a woman's health long after the reproductive phase has ended.

Quick Summary

After 65, ovaries are not hormonally dormant; they continue producing small amounts of androgens like testosterone and androstenedione, which are converted into a weak form of estrogen in fat and muscle tissue. This persistent hormonal activity plays a role in maintaining bone density, libido, and overall health.

Key Points

  • Continued Hormone Production: Ovaries continue to produce androgens, like testosterone, long after menopause, sometimes until age 80.

  • Peripheral Conversion: These androgens are converted into estrone, a form of estrogen, in fat and muscle tissue throughout the body.

  • Shrinking and Atrophy: Physically, the ovaries shrink and undergo fibrosis as part of the natural aging process.

  • Impact on Bone Health: The low but persistent hormone levels help maintain bone density and reduce the risk of osteoporosis.

  • Influence on Libido: Ovarian-produced androgens are important for maintaining sexual desire and function in postmenopausal women.

  • Risk of Removal: Elective oophorectomy (ovary removal) after menopause is associated with increased risks of osteoporosis, cardiovascular disease, and reduced sexual function compared to retaining the ovaries.

  • Endocrine Importance: The postmenopausal ovary is not an inert organ, and its persistent endocrine activity is being increasingly recognized as vital for healthy aging.

In This Article

The Postmenopausal Ovarian Landscape

For many, menopause is viewed as the final chapter in ovarian function. While it is true that the production of estrogen and progesterone plummets, and the ovaries shrink significantly in size and change in structure, they do not cease to function entirely. Postmenopausal ovaries, though smaller and atrophic, are not hormonally silent. They shift from primarily producing female reproductive hormones to producing androgens, or 'male hormones', which continue to contribute to a woman's overall endocrine profile for many years.

Imaging techniques, such as ultrasounds, show that postmenopausal ovaries become smaller and can sometimes be difficult to visualize. Histologically, they undergo significant changes, including fibrosis and atrophy of the stromal tissue, the connective tissue that makes up the bulk of the ovary. However, the remaining stromal cells are still capable of responding to signals and secreting hormones.

The Persistent Hormonal Activity of Ovaries

Long after a woman's final menstrual cycle, the postmenopausal ovary continues to produce hormones, notably testosterone and androstenedione. This production can persist for decades, with studies observing this activity even 10 to 20 years past menopause. These androgens are crucial because they serve as precursors for a weak form of estrogen called estrone. The conversion process, known as aromatization, happens in peripheral tissues throughout the body, including fat, muscle, and skin.

This low but persistent level of hormone production is far from insignificant. It provides a baseline hormonal presence that has measurable effects on a woman's body. The continuation of this endocrine activity is what separates the experience of natural menopause from a surgical menopause (oophorectomy), where the ovaries are removed and this hormone source is abruptly cut off. The continued presence of even small amounts of hormones can make a noticeable difference in a woman's health as she ages.

Critical Contributions to Senior Health

The hormones produced by postmenopausal ovaries, particularly the androgens and the resulting estrone, play a vital role in several aspects of healthy aging. Their impact extends to areas often associated with menopausal hormone decline, including:

  • Bone Health: Both androgens and estrogens help inhibit bone resorption, the process by which old bone is broken down. Androgens can also stimulate bone formation. For this reason, women who retain their ovaries after menopause have been shown to have a lower risk of osteoporotic fractures compared to those who have them surgically removed.
  • Sexual Function: Androgens, including testosterone, are important for maintaining libido and sexual function. Research has demonstrated that bilateral oophorectomy significantly reduces circulating androgen levels in postmenopausal women, which can lead to a decline in sexual desire and function.
  • Cardiovascular Health: The small amounts of hormones produced by postmenopausal ovaries also have a protective effect on the cardiovascular system. Studies have linked the removal of ovaries to an increased risk of cardiovascular disease, further underscoring the benefits of retaining them when possible.

Ovarian Conservation vs. Removal After Menopause

While there is an increased risk of ovarian cancer associated with age, and half of all cases are diagnosed in women over 63, the benefits of retaining ovaries in postmenopausal women with no genetic risk factors have become a topic of discussion. This has led to a reevaluation of the practice of prophylactic oophorectomy during hysterectomy in postmenopausal women. A decision on ovarian conservation should be made in consultation with a healthcare provider and weighed against a woman's individual risk factors.

Feature Ovaries Conserved After Menopause Ovaries Removed (Oophorectomy) After Menopause
Androgen Production Continues, providing low but steady levels of testosterone and androstenedione. Abruptly ceases, causing a significant drop in circulating androgens.
Estrogen Production Minimal, primarily from peripheral conversion of androgens to estrone. Also minimal, relying entirely on conversion in adrenal glands and fat cells.
Bone Health Helps maintain bone density and lowers risk of osteoporotic fractures. Associated with increased rate of bone loss and higher fracture risk.
Cardiovascular Risk Small protective effect from ongoing endocrine activity. Potentially increased risk of cardiovascular disease.
Sexual Function Androgens contribute to maintenance of libido and sexual arousal. Potential decline in libido and sexual function.

The Future of Ovarian Aging Research

Scientific interest in the postmenopausal ovary is growing. Researchers now recognize that ovarian aging is a key driver of overall aging and that lessons learned from studying it could offer broader insights into the aging process for all. The field of geroscience is actively exploring how to extend the benefits of healthy ovarian function to women who have passed menopause, not to extend fertility, but to promote overall health and longevity.

This research suggests that targeting the mechanisms of ovarian aging, such as cellular damage and inflammation, could lead to therapies that improve the healthspan—the period of life spent in good health—for women. A better understanding of this complex process will continue to inform treatment strategies and change the way both patients and doctors view the role of the ovaries in later life.

For more information on the ongoing research into the biology of aging, including ovarian aging, visit the National Institute on Aging at www.nia.nih.gov.

Conclusion: The Enduring Legacy

The idea that ovaries become obsolete after menopause is a myth. Far from being functionless, the postmenopausal ovaries remain active endocrine organs. Their ongoing, albeit low-level, production of androgens contributes significantly to a woman's overall health and well-being, affecting bone density, cardiovascular health, and sexual function. Recognizing the enduring role of the ovaries is crucial for a more nuanced approach to women's health in the later stages of life.

Frequently Asked Questions

Ovaries shrink after menopause due to the depletion of follicles and the progressive atrophy and fibrosis of the ovarian stromal tissue. This is a normal part of the aging process as their reproductive function ceases.

After 65, the ovaries primarily produce androgens, including testosterone and androstenedione. These androgens are then converted in the body's peripheral tissues into a weaker estrogen called estrone.

The small amounts of androgens and estrogens produced by the postmenopausal ovaries play a role in inhibiting bone resorption, helping to maintain bone density and reducing the risk of osteoporosis and fractures.

Yes, removing ovaries (oophorectomy) after menopause can lead to a more pronounced decline in hormone levels, potentially increasing the risks of osteoporosis, cardiovascular disease, and negatively impacting sexual function and libido.

The androgens produced by the postmenopausal ovaries are known to contribute to a woman's libido and sexual function. A decline in these hormones, whether natural or from surgical removal, can reduce sexual desire.

Because the ovaries shrink significantly after menopause, they can sometimes be difficult for doctors to visualize on imaging like ultrasounds, though this is considered normal and is not a cause for concern in and of itself.

The production of androgens after menopause is important for more than just sexual function. It also contributes to bone strength, muscle mass, and overall energy levels.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.